GHDx
Published on GHDx (https://ghdx.healthdata.org)


Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. Preprint

General Info

Geography 
Japan (JPN)
Tōkyō
Coverage type 
Subnational
Time period covered 
January, 2020 - December, 2020
Data type
Scientific literature
Keywords 
COVID-19, Disease outbreaks

Citation

Authors 
Takita M, Matsumura T, Yamamoto K, Yamashita E, Hosoda K, Hamaki T, Kusumi E
Journal 
medRxiv
Publication year 
2020
Suggested citation 
Takita M, Matsumura T, Yamamoto K, Yamashita E, Hosoda K, Hamaki T, Kusumi E. Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing. Preprint. medRxiv. 2020.

Source URL:https://ghdx.healthdata.org/record/regional-difference-seroprevalence-sars-cov-2-tokyo-results-community-point-care-antibody